Just Biotherapeutics raises $14M

Just Biotherapeutics Inc. (Seattle, Wash.) raised $14 million in a series A2 round. The Bill & Melinda Gates Foundation invested $8 million of the new money. Existing investors Merck & Co. Inc. (NYSE:MRK), Lilly Asia Ventures and Arch Venture Partners each contributed $2 million.

Just says its technology is designed to lower the costs of designing molecules and manufacturing biologics. It plans to use the funds to build its integrated lab infrastructure and a pilot plant, and to add GMP capabilities. The company is seeking to apply its technology in both developing and developed markets. ...